Back

Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report

2020-06-22 infectious diseases Title + abstract only
View on medRxiv
Show abstract

BackgroundCoronavirus disease 2019 (COVID-19) is associated with diffuse lung damage. Corticosteroids may modulate immune-mediated lung injury and reducing progression to respiratory failure and death. MethodsThe Randomised Evaluation of COVID-19 therapy (RECOVERY) trial is a randomized, controlled, open-label, adaptive, platform trial comparing a range of possible treatments with usual care in patients hospitalized with COVID-19. We report the preliminary results for the comparison of dexameth...

Predicted journal destinations

1
BMJ Open
553 training papers
Top 21% 7.2%
2
PLOS ONE
1737 training papers
Top 69% 7.2%
3
Clinical Infectious Diseases
219 training papers
Top 3% 7.2%
4
Open Forum Infectious Diseases
124 training papers
Top 1% 5.5%
5
New England Journal of Medicine
49 training papers
Top 0.5% 4.6%
6
The Journal of Infectious Diseases
137 training papers
Top 3% 3.9%
7
JAMA Network Open
125 training papers
Top 4% 3.9%
8
Nature Communications
483 training papers
Top 30% 3.6%
9
Scientific Reports
701 training papers
Top 70% 3.6%
10
The Lancet Respiratory Medicine
16 training papers
#1 3.6%
11
BMC Medicine
155 training papers
Top 14% 1.8%
12
Nature Medicine
88 training papers
Top 4% 1.8%
13
BMC Infectious Diseases
110 training papers
Top 9% 1.8%
14
BMJ
49 training papers
Top 2% 1.8%
15
eClinicalMedicine
55 training papers
Top 0.6% 1.8%
16
Clinical Microbiology and Infection
54 training papers
Top 2% 1.8%
17
International Journal of Infectious Diseases
115 training papers
Top 14% 1.4%
18
eLife
262 training papers
Top 32% 1.4%
19
Frontiers in Medicine
99 training papers
Top 13% 1.4%
20
PLOS Medicine
95 training papers
Top 10% 1.4%
21
European Respiratory Journal
44 training papers
Top 3% 1.2%
22
Journal of Infection
64 training papers
Top 5% 1.2%
23
Vaccine
140 training papers
Top 7% 1.2%
24
JCI Insight
63 training papers
Top 6% 1.2%
25
The Lancet Infectious Diseases
57 training papers
Top 5% 1.1%
26
The Lancet
16 training papers
#1 1.1%
27
Journal of Infection and Public Health
15 training papers
Top 0.5% 0.9%
28
PLOS Global Public Health
287 training papers
Top 31% 0.9%
29
Frontiers in Immunology
140 training papers
Top 12% 0.9%
30
Trials
24 training papers
Top 2% 0.9%